$211.1M in CY2024 Part D spend126K claims · 17K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Eslicarbazepine used for?
Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Is there a generic for Eslicarbazepine?
Yes. 32 ANDAs filed at FDA, 8 generic manufacturers currently shipping.
How much does my plan pay for Eslicarbazepine?
Across 329 Part D plans, Eslicarbazepine averages $3.34/unit (NADAC). Lowest available: $3.05/unit. Highest in distribution: $3.92/unit.
Is Eslicarbazepine on the FDA shortage list?
No. Eslicarbazepine is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.